Roche was founded in 1896 in Basel, Switzerland with a clear focus on a unique innovation model. It is now one of the world's largest biotech companies with truly differentiated medicines in oncology, virology, inflammation, metabolism and neurology; and a leader in in-vitro diagnostics, and a pioneer in diabetes management. At Roche, personalized healthcare - also known as PHC – is a key area of focus, combining pioneering science, data, analytics and technology to advance new discoveries and improve patients' lives. In order to bring the promise of personalized healthcare to life, Roche is focusing on four key aspects of care: • Early detection and accurate diagnosis • Individualized care • Access to optimal care • Remote care and monitoring This continuous investment in research has provided notable results with 32 Roche medicines being included in the WHO- essential medicines list. Roche employs 100,920 people globally. Roche has been in the Philippines for more than 57 years and continues to find and develop ways to help prevent, diagnose and treat diseases, and make a sustainable contribution to the Filipino society. Recently, Roche has changed its engagement model to focus on health system shaping where its employees work with patient groups, health care professionals, government, and other stakeholders to try to help create an environment and system where each person can better access innovative medicines to help save or improve lives. We hope to impact all Filipinos whether they are engineers in the city or farmers in the country-side.